Laubli, H; Varki, A; Borsig, L (2016). Antimetastatic properties of low molecular weight heparin. Journal of Clinical Oncology, 34(21):2560-2561.
Stevenson, J L; Varki, A; Borsig, L (2007). Heparin attenuates metastasis mainly due to inhibition of P- and L-selectin, but non-anticoagulant heparins can have additional effects. Thrombosis Research, 120(Suppl):S107-S111.